about
Rathke's cleft cyst rupture as potential initial event of a secondary perifocal lymphocytic hypophysitis: proposal of an unusual pathogenetic event and review of the literature.Sellar neuroblastoma mimicking a pituitary tumour: case report and review of the literature.Postoperative intracranial seeding of craniopharyngiomas--report of three cases and review of the literature.The development of the Tuebingen Cushing's disease quality of life inventory (Tuebingen CD-25). Part II: normative data from 1784 healthy people.Treatment Options in Cushing's Disease.Primary intrasellar schwannoma: clinical, aetiopathological and surgical considerations.Glioblastoma with granular cell astrocytoma features: a case report and literature review.Transcriptome analysis of MENX-associated rat pituitary adenomas identifies novel molecular mechanisms involved in the pathogenesis of human pituitary gonadotroph adenomas.Validation of the Tuebingen CD-25 Inventory as a Measure of Postoperative Health-Related Quality of Life in Patients Treated for Cushing's Disease.From first symptoms to final diagnosis of Cushing's disease: experiences of 176 patients.Aftercare in patients with Cushing's disease and acromegaly: is there room for improvement?Are there gender-specific differences concerning quality of life in treated acromegalic patients?No evidence for WT1 involvement in a beta-catenin-independent activation of the Wnt signaling pathway in pituitary adenomas.Tuebingen CD-25 is a sensitive tool to investigate health-related quality of life in Cushing's disease patients in the course of the disease.Atypical type II silent corticotrophic adenoma developing into Cushing's disease upon second recurrence.Coping strategies have a strong impact on quality of life, depression, and embitterment in patients with Cushing's disease.Notch receptors in human choroid plexus tumors.Pituitary adenomas and craniopharyngiomas are CDX2 negative neoplasms.Health-related quality of life and psychiatric symptoms improve effectively within a short time in patients surgically treated for pituitary tumors--a longitudinal study of 106 patients.Similar psychopathological profiles in female and male Cushing's disease patients after treatment but differences in the pathogenesis of symptoms.ACTH- and prolactin-producing pituitary gland microadenoma with biphasic features of atypia and intermediate filament expression.The development of the Tuebingen Cushing's disease quality of life inventory (Tuebingen CD-25). Part I: construction and psychometric properties.Predictive factors for neurocognitive function and Quality of Life after surgical treatment for Cushing's disease and acromegaly.Executive functions recover earlier than episodic memory after microsurgical transsphenoidal resection of pituitary tumors in adult patients--a longitudinal study.Cerebral low-grade lymphoma and light chain deposition disease: exceedingly high IgG levels in the cerebrospinal fluid as a diagnostic clue.Contemporary microsurgical concept for the treatment of Cushing’s disease: endocrine outcome in 83 consecutive patients
P50
Q31145611-D5DA77AF-B84E-45A6-884F-06BBD072D004Q33488421-C16E6EFE-D9EF-4E0E-9E31-9A456107A253Q33512936-FB19A8BA-F39B-46CA-8CEC-09457BFFD857Q34069860-380F5180-B003-44AE-B676-56F1E153897DQ35740882-FD4ACE6B-5401-4833-9D17-5656B8E8E1ADQ36385447-8DC558CB-E162-41F9-9516-0109DED9B847Q37791246-314F8F5B-606D-4FDB-BDE9-A34073FA1AA3Q39140897-2B2EA0B3-2442-4079-88A5-2A6605AF0AEEQ40946135-3438BB5C-244A-4471-A1B8-296C8E4D8B81Q41697022-3BAF9C0C-3B5D-41BB-A877-A06D8D39E1C3Q43243006-E3ADF699-1D4D-4393-842D-02ADACAF74F4Q43523083-A2B80502-DF7A-44B4-93CA-2A3519D82F25Q44080641-BE48E04F-A897-4F20-9A11-1DEE46FFB55EQ44583394-29952AB3-7680-4E72-9749-3A734FC0EB28Q46944528-196CB075-B434-4A1C-AB85-EBD5FA1DBF89Q47634665-792E3B52-6536-4566-BBF0-1A275EA1D938Q48131202-91589833-573E-42A6-BD68-C970C5E0029BQ48139934-77CA5A41-7684-40EF-8DD4-81A88F2AA063Q48210650-801074DB-0656-4BA4-B68F-36744B51FA9BQ48279463-D74392E6-5B64-497E-AFC8-CA9CE6D5DCC3Q48560966-3BEC0570-64AC-479A-A14F-AB3C22B42665Q48621132-1283E549-B26E-477E-914F-72680BEC02B2Q48766481-9E175F34-CF8F-4B15-83C7-EA16BD68B5DCQ50998965-20A87FC5-A53D-4AC2-B2AE-66FDA9179C67Q55463681-154251FF-D119-482A-8EC7-F480756F3EFCQ56964307-C0FDC20D-C9F8-411F-9AC2-1622F11D07F8
P50
description
onderzoeker
@nl
name
Tsambika Psaras
@ast
Tsambika Psaras
@en
Tsambika Psaras
@es
Tsambika Psaras
@nl
Tsambika Psaras
@sl
type
label
Tsambika Psaras
@ast
Tsambika Psaras
@en
Tsambika Psaras
@es
Tsambika Psaras
@nl
Tsambika Psaras
@sl
prefLabel
Tsambika Psaras
@ast
Tsambika Psaras
@en
Tsambika Psaras
@es
Tsambika Psaras
@nl
Tsambika Psaras
@sl